Popular Boards

Abstract

Emerging evidence suggests that modulation of gut microbiota by dietary fibre may offer solutions for metabolic disorders. In a randomized placebo-controlled crossover design trial (ChiCTR-TTRCC-13003333) in 37 participants with overweight or obesity, we test whether resistant starch (RS) as a dietary supplement influences obesity-related outcomes. Here, we show that RS supplementation for 8 weeks can help to achieve weight loss (mean -2.8 kg) and improve insulin resistance in individuals with excess body weight. The benefits of RS are associated with changes in gut microbiota composition. Supplementation with Bifidobacterium adolescentis, a species that is markedly associated with the alleviation of obesity in the study participants, protects male mice from diet-induced obesity. Mechanistically, the RS-induced changes in the gut microbiota alter the bile acid profile, reduce inflammation by restoring the intestinal barrier and inhibit lipid absorption. We demonstrate that RS can facilitate weight loss at least partially through B. adolescentis and that the gut microbiota is essential for the action of RS.

Tags

Plain English Takeaway

Eating a special kind of starch that your body can't digest helps people lose weight by changing the types of bacteria in their gut. These changes also make the body handle sugar better and reduce inflammation.

Study Aim

The main goal of this study was to find out if taking resistant starch (RS—a type of dietary fiber that resists digestion in the small intestine and is fermented by gut bacteria) as a supplement could help people with overweight or obesity lose weight and improve their metabolism. The researchers also wanted to understand how changes in the gut microbiota (the community of bacteria living in the intestines) might be responsible for these effects. Simply put: The study wanted to see if a special fiber could help people lose weight by changing their gut bacteria.

Study Design

The researchers conducted a randomized, double-blind, placebo-controlled crossover trial with 37 adults who were overweight or obese. Each participant consumed either resistant starch (RS) or a control starch (CS) for 8 weeks, with a 4-week break in between. All participants ate the same balanced diet during the study. The team measured body weight, fat, waist size, insulin sensitivity, and gut bacteria before and after each intervention. They also transplanted gut bacteria from human participants into mice to see if the effects could be reproduced in animals. Simply put: The study gave people a special starch or a regular starch, checked their health and gut bacteria, and tested the results in mice.

Findings

The study reveals that 8 weeks of resistant starch (RS) supplementation led to significant weight loss (average 2.8 kg), reduced fat mass, and smaller waistlines compared to the control starch. RS also improved insulin sensitivity and lowered inflammation markers. These benefits were linked to changes in the gut microbiota, especially an increase in Bifidobacterium adolescentis (a beneficial gut bacterium). When gut bacteria from RS-treated humans were transplanted into mice, the mice also lost weight and had better metabolism. The research demonstrates that RS works by reshaping the gut microbiota, which in turn changes bile acids, strengthens the gut barrier, reduces inflammation, and limits fat absorption. The presence of B. adolescentis was key to these effects, and RS did not work in germ-free mice unless B. adolescentis was added. The authors recommend RS as a dietary supplement for weight loss, but note that long-term effects and broader applicability need further study. Simply put: Eating resistant starch helped people lose weight and improved their health by changing their gut bacteria, and these changes were important for the benefits.

Referenced In

[Physionic] Resistant Starch is OP?

www.youtube.comI watched this great video from Physionic on the scientific literature on resistant starch and its impact on visceral fat and liver health. Very compelling evidence via placebo controlled RCTs on resistant starch's ability to treat Metabolic dysfunction-associated steatotic liver disease (MASLD) or fka NAFLD and weight loss plus 6 more studies as provided by Physionic. He states that compared to placebo, the studies show 300% relative or 20% absolute improvement in reducing visceral fat.

Visceral fat, the fat that surrounds internal organs, can put people at higher risk for several diseases like cardiovascular disease and specifically contributes to fatty liver disease, even when compared to other fat types.

The most common type of resistant starch (RS3) is formed when the starch in foods like rice, pasta, and potatoes is cooked and then cooled allowing the starch to crystallize in a process called retrogradation. The starch becomes undigestible for humans but becomes fuel for our gut microbiome. Raw starch (RS2) found in potato starch, green bananas, or high-amylose maize acts similarly and is most commonly used in supplements.

The theoretical biological mechanism for this improvement is via the reduction of a harmful bacteria that is crowded out by other bacteria that thrive on resistant starch. Even more interesting, Physionic found that 70% are hyper-responders to resistant starch.

Resistant starch, because indigestible, packs significantly less caloric and carbohydrate punch than its non-resistant version. But these studies show that it goes beyond harm reduction. Resistant starch can have positive effects especially with supplementation to reach minimum effective doses.

6